Mounting Rx Lawsuits Expose Ongoing Concerns Over FDA's Revolving Door

Wisner Baum says the FDA "revolving door," or the movement of regulators into pharmaceutical industry jobs, is raising renewed concerns about conflicts of interest and public trust as litigation involving blockbuster prescription drugs continues to grow nationwide. LOS ANGELES, May 26,...